Management of coexisting conditions in the context of COVID-19

References

Reference articles

1. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynaecol Obstet. 2020 Jun;149(3):273-86.Full text  Abstract

2. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2021 Mar 12:70(10);355-61.Full text  Abstract

3. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-54.Full text  Abstract

4. International Federation of Gynecology and Obstetrics. Safe motherhood and COVID-19 – March 2021 update. 2021 [internet publication].Full text

5. Epelboin S, Labrosse J, De Mouzon J, et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: a national retrospective cohort study. PLoS Med. 2021 Nov 30;18(11):e1003857.Full text  Abstract

6. Knight M, Bunch K, Cairns A, et al on behalf of MBRRACE-UK. Saving lives, improving mothers’ care rapid report: learning from SARS-CoV-2-related and associated maternal deaths in the UK March – May 2020. National perinatal epidemiology Unit, University of Oxford. Aug 2020 [internet publication].Full text

7. Healthcare Quality Improvement Partnership. Maternal, newborn and infant clinical outcome review programme rapid report, 2021: learning from SARS-CoV-2 related and associated maternal deaths in the UK. Jul 2021 [internet publication].Full text

8. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and pregnancy. Mar 2022 [internet publication].Full text

9. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020 Jun 8;369:m2107.Full text  Abstract

10. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020 Jun 26;69(25):769-75.Full text

11. Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020 Sep 23;324(17):1782-5.Full text  Abstract

12. Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635-40.Full text  Abstract

13. Jering KS, Claggett BL, Cunningham JW, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021 May 1;181(5):714-7.Full text  Abstract

14. Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021 Nov;225(5):522.e1-522.e11.Full text  Abstract

15. Piekos SN, Roper RT, Hwang YM, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit Health. 2022 Jan 13;4(2):e95-104.Full text  Abstract

16. Marchand G, Patil AS, Masoud AT, et al. Systematic review and meta-analysis of COVID maternal and neonatal clinical features and pregnancy outcomes to June 3rd 2021. AJOG Glob Rep. 2022 Feb;2(1):100049.Full text  Abstract

17. Metz TD, Clifton RG, Hughes BL, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022 Feb 22;327(8):748-59.Full text  Abstract

18. Ferrara A, Hedderson M, Zhu Y, et al. Perinatal complications in individuals in California with or without SARS-CoV-2 infection during pregnancy. JAMA Intern Med. 2022 May 1;182(5):503-12.Full text  Abstract

19. McClymont E, Albert AY, Alton GD, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2 May 2022 [Epub ahead of print].Full text  Abstract

20. Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics — eight U.S. health care centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 23;69(38):1355-9.Full text  Abstract

21. Khoury R, Bernstein PS, Debolt C, et al. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstet Gynecol. 2020 Aug;136(2):273-82.Full text  Abstract

22. Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021 Apr 1;137(4):571-80.Full text  Abstract

23. Flaherman VJ, Afshar Y, Boscardin J, et al. Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study. Clin Infect Dis. 2021 Nov 2;73(9):e2810-13.Full text  Abstract

24. Vousden N, Ramakrishnan R, Bunch K, et al. Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, Alpha, and Delta variant dominance in the UK: prospective cohort study. BMJ Medicine. 2022 Mar 9;1:e000053.Full text

25. Norman M, Navér L, Söderling J, et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA. 2021 May 25;325(20):2076-86.Full text  Abstract

26. DeSisto CL, Wallace BL, Simeone RM, et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization - United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1640-45.Full text  Abstract

27. Allotey J, Chatterjee S, Kew T, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022 Mar 16;376:e067696.Full text  Abstract

28. International Federation of Gynecology and Obstetrics. COVID-19 vaccination for pregnant and breastfeeding women. Mar 2021 [internet publication].Full text

29. American College of Obstetricians and Gynecologists (ACOG). COVID-19 vaccination considerations for obstetric–gynecologic care. Apr 2022 [internet publication].Full text

30. Centers for Disease Control and Prevention. Information about COVID-19 vaccines for people who are pregnant or breastfeeding. Mar 2022 [internet publication].Full text

31. UK Health Security Agency. COVID-19: the green book, chapter 14a: Coronavirus (COVID-19) vaccination information for public health professionals. Feb 2022 [internet publication].Full text

32. Adhikari EH, MacDonald L, SoRelle JA, et al. COVID-19 cases and disease severity in pregnancy and neonatal positivity associated with Delta (B.1.617.2) and Omicron (B.1.1.529) variant predominance. JAMA. 2022 Apr 19;327(15):1500-2.Full text  Abstract

33. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 vaccination in pregnancy with adverse peripartum outcomes. JAMA. 2022 Apr 19;327(15):1478-87.Full text  Abstract

34. Magnus MC, Örtqvist AK, Dahlqwist E, et al. Association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes. JAMA. 2022 Apr 19;327(15):1469-77.Full text  Abstract

35. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021 Jun 17;384(24):2273-82. Abstract

36. Zauche L, Wallace B, Smoots AN, et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N Engl J Med. 2021 Oct 14;385(16):1533-5.Full text  Abstract

37. Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA. 2021 Oct 26;326(16):1629-31.Full text  Abstract

38. Magnus MC, Gjessing HK, Eide HN. et al. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med. 2021 Nov 18;385(21):2008-10.Full text  Abstract

39. UK Health Security Agency. COVID-19 vaccine weekly surveillance reports (weeks 39 to 50). Apr 2022 [internet publication].Full text

40. Lipkind HS, Vazquez-Benitez G, DeSilva M, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):26-30.Full text  Abstract

41. Hillson K, Costa Clemens S, Madhi SA, et al. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet. 2021 Nov 6;398(10312):1683-4.Full text  Abstract

42. Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gynecol. 25 Jan 2022 [Epub ahead of print].Full text  Abstract

43. Magee LA, von Dadelszen P, Kalafat E, et al. COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm. Lancet Infect Dis. 2021 Dec;21(12):1627.Full text  Abstract

44. Gill L, Jones C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol. 2021 May 1;137(5):894-6.Full text  Abstract

45. Perl S, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021 May 18;325(19):2013-4.Full text  Abstract

46. Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021 Sep;225(3):303.Full text  Abstract

47. Halasa NB, Olson SM, Staat MA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months - 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):264-70.Full text  Abstract

48. Berthelot N, Lemieux R, Garon-Bissonnette J, et al. Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic. Acta Obstet Gynecol Scand. 2020 Jul;99(7):848-55.Full text  Abstract

49. Papworth R, Harris A, Durcan G, et al. Maternal mental health during a pandemic. A rapid evidence review of Covid-19's impact. Mar 2021 [internet publication].Full text

50. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Guidance for antenatal and postnatal services in the evolving coronavirus (COVID-19) pandemic. Oct 2020 [internet publication].Full text

51. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Considerations for inpatient obstetric healthcare settings. Nov 2021 [internet publication].Full text

52. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics. Mar 2022 [internet publication].Full text

53. World Health Organization. Clinical management of COVID-19: living guidance. Nov 2021 [internet publication].Full text

54. American Academy of Pediatrics. FAQs: management of infants born to mothers with suspected or confirmed COVID-19. Dec 2021 [internet publication].Full text

55. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020 Oct;4(10):721-7.Full text  Abstract

56. Dumitriu D, Emeruwa UN, Hanft E, et al. Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City. JAMA Pediatr. Oct 2020 [internet publication].Full text  Abstract

57. Ronchi A, Pietrasanta C, Zavattoni M, et al. Evaluation of rooming-in practice for neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection in Italy. JAMA Pediatr. 2021 Mar 1;175(3):260-6.Full text  Abstract

58. Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr. 2021 Jun 1;175(6):594-600.Full text  Abstract

59. Royal College of Paediatrics and Child Health. BAPM - COVID-19: frequently asked questions within neonatal settings. Jan 2022 [internet publication].Full text

60. Resuscitation Council UK. COVID-19 resources: newborn life support. Sep 2021 [internet publication].Full text

61. Centers for Disease Control and Prevention. Care for breastfeeding women. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. Dec 2021 [internet publication].Full text

62. Chambers C, Krogstad P, Bertrand K, et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020 Oct 6;324(13):1347-8.Full text  Abstract

63. Elliott J, Bodinier B, Whitaker M, et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur J Epidemiol. 2021 Mar;36(3):299-309.Full text  Abstract

64. American Academy of Dermatology. Clinical guidance for COVID-19. 2020 [internet publication].Full text

65. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response. Apr 2021 [internet publication].Full text

66. Gadarowski MB, Balogh EA, Bashyam AM, et al. Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries. J Dermatolog Treat. Oct 2020 [internet publication].Full text  Abstract

67. Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy. 2020 Nov;75(11):2764-74. Abstract

68. International Psoriasis Council. IPC statement on the coronavirus (COVID-19) outbreak. Sep 2020 [internet publication].Full text

69. European Association of Dermatology and Venereology (EADV). Management of psoriasis patients under systemic treatments. Apr 2020 [internet publication].Full text

70. International Eczema Council. IEC statement on COVID-19. 2020 [internet publication].Full text

71. Specialist Pharmacy Service. Using COVID-19 vaccines in patients taking immunosuppressive medicines. Mar 2022 [internet publication].Full text

72. Gelfand JM, Armstrong AW, Bell S, et al. National psoriasis foundation COVID-19 task force guidance statements. Apr 2022 [internet publication].Full text

73. Kasperkiewicz M, Schmidt E, Fairley JA, et al. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-3.Full text  Abstract

74. Wollenberg A, Flohr C, Simon D, et al. European task force on atopic dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-2.Full text  Abstract

75. British Association of Dermatologists. Dermatology advice regarding medication acting on the immune system: adults, paediatrics and young people. Nov 2020 [internet publication].Full text

76. Medicines and Healthcare products Regulatory Agency. Temporary advice for management of oral retinoid medicines during the COVID-19 pandemic. Jun 2021 [internet publication].Full text

77. National Institute for Health and Care Excellence. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response. Apr 2021 [internet publication].Full text

78. American Association for the Study of Liver Diseases. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Nov 2021 [internet publication].Full text

79. Boettler T, Marjot T, Newsome PN, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep. 2020 Oct;2(5):100169.Full text  Abstract

80. NHS England. Triaging patients with lower gastrointestinal symptoms. Jun 2020 [internet publication].Full text

81. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Dec 2021 [internet publication].Full text

82. Gralnek IM, Hassan C, Beilenhoff U, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. 2020 Jun;52(6):483-90.Full text  Abstract

83. Chiu PW, Ng SC, Inoue H, et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020 Jun;69(6):991-6.Full text  Abstract

84. Gralnek I, Hassan C, Beilenhoff U, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and COVID-19: an update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy. 2020 Oct;52(10):891-8.Full text  Abstract

85. Sultan S, Siddique SM, Altayar O, et al. AGA institute rapid review and recommendations on the role of pre-procedure SARS-CoV2 testing and endoscopy. Gastroenterology. 2020 Nov;159(5):1935-48.e5.Full text  Abstract

86. Walsh CM, Fishman DS, Lerner DG, et al. Pediatric endoscopy in the era of coronavirus disease 2019: a North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper. J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):741-50.Full text  Abstract

87. Wong GL, Wong VW, Thompson A, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-87.Full text  Abstract

88. World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Feb 2020 [internet publication].Full text

89. Ng WH, Tipih T, Makoah N, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9;12(1):e03647-20.Full text  Abstract

90. Pinato DJ, Zambelli A, Aguilar-Company J, et al. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020 Oct 1;10(10):1465-74.Full text  Abstract

91. Jee J, Foote MB, Lumish M, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020 Aug 14:JCO2001307.Full text  Abstract

92. Chavez-MacGregor M, Lei X, Zhao H, et al. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol. 2022 Jan 1;8(1):69-78.Full text  Abstract

93. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1309-16.Full text  Abstract

94. Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021 Feb 1;7(2):220-7.Full text  Abstract

95. Fair Health. Risk factors for COVID-19 mortality among privately insured patients: a claims data analysis. Nov 2020 [internet publication].Full text

96. OnCovid Study Group; Pinato DJ, Patel M, et al. Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry. JAMA Oncol. 2022 Jan 1;8(1):114-22.Full text  Abstract

97. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. Feb 2021 [internet publication].Full text

98. Weinkove R, McQuilten ZK, Adler J, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020 Jun;212(10):481-9.Full text  Abstract

99. National Institute for Health and Care Excellence. Interim treatment change options during the COVID-19 pandemic, endorsed by NHS England. Apr 2022 [internet publication].Full text

100. European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2021 [internet publication].Full text

101. Curigliano G, Banerjee S, Cervantes A, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary expert consensus. Ann Oncol. 2020 Oct;31(10):1320-35.Full text  Abstract

102. Marron JM, Joffe S, Jagsi R, et al. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J Clin Oncol. 2020 Jul 1;38(19):2201-5.Full text  Abstract

103. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Apr 2022 [internet publication].Full text

104. American College of Cardiology. Delivery of cardio-oncology care during the COVID-19 pandemic. Jun 2020 [internet publication].Full text

105. Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021 Aug 26;22(10):1416-26.Full text  Abstract

106. Pinato DJ, Tabernero J, Bower M, et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021 Dec;22(12):1669-80.Full text  Abstract

107. American Society of Clinical Oncology. COVID-19 vaccines & patients with cancer. Feb 2022 [internet publication].Full text

108. UK Chemotherapy Board. Clinicians FAQs and guidance on COVID-19 vaccine for patients receiving systemic anti-cancer therapy. Dec 2021 [internet publication].Full text

109. Goshen-Lago T, Waldhorn I, Holland R, et al. Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer. JAMA Oncol. 2021 Oct 1;7(10):1507-13.Full text  Abstract

110. Fendler A, Shepherd ST, Au L, et al. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2021 Dec;2(12):1305-20.Full text

111. Oosting SF, van der Veldt A, GeurtsvanKessel CH, et al. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. Lancet Oncol. 2021 Dec;22(12):1681-91.Full text  Abstract

112. Wang W, Kaelber DC, Xu R, et al. Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021. JAMA Oncol. 8 Apr 2022 [Epub ahead of print].Full text  Abstract

113. Schmidt AL, Labaki C, Hsu CY, et al. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 Mar;33(3):340-6.Full text  Abstract

114. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of radiotherapy. Feb 2021 [internet publication].Full text

115. Yahalom J, Dabaja BS, Ricardi U, et al. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic. Blood. 2020 May 21;135(21):1829-32.Full text  Abstract

116. Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 May;146:223-9.Full text  Abstract

117. Liao Z, Rivin Del Campo E, Salem A, et al. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer. 2020 Aug;146:230-5.Full text  Abstract

118. Mehanna H, Hardman JC, Shenson JA, et al. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol. 2020 Jul;21(7):e350-9.Full text  Abstract

119. COVID-19 and people with neuromuscular disorders: World Muscle Society position and advice. Apr 2022 [internet publication].Full text

120. Jia N, Zhang G, Sun X, et al. Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: a systemic review and meta-analysis. J Clin Hypertens (Greenwich). 2021 Sep;23(9):1651-63.Full text  Abstract

121. Asiimwe IG, Pushpakom S, Turner RM, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Dec;87(12):4534-45.Full text  Abstract

122. Asiimwe I, Pushpakom S, Turner R, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 24 Mar 2022 [Epub ahead of print].Full text  Abstract

123. Peñalvo J, Genbrugge E, Mertens E, et al. Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium. BMJ Open. 2021 Sep 16;11(9):e053393.Full text  Abstract

124. Khodneva Y, Malla G, Clarkson S, et al. What is the association of renin-angiotensin-aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients? BMJ Open. 2022 Apr 12;12(4):e053961.Full text  Abstract

125. British Cardiovascular Society and British Society for Heart Failure. BSH & BCS joint statement on ACEi or ARB in relation to COVID-19. Mar 2020 [internet publication].Full text

126. European Society of Cardiology Council on Hypertension. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Mar 2020 [internet publication].Full text

127. American Heart Association, Heart Failure Society of America, American College of Cardiology. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. Mar 2020 [internet publication].Full text

128. Kario K, Morisawa M, Sukonthasarn A, et al. COVID-19 and hypertension-evidence and practical management: guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2020 Jul;22(7):1109-19.Full text  Abstract

129. Lee SW, Ha EK, Yeniova AO, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut. 2021 Jan;70(1):76-84.Full text  Abstract

130. Kim HB, Kim JH, Wolf BJ. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2021 Nov 24;1-9.Full text  Abstract

131. World Health Organization. Guiding principles for immunization activities during the COVID-19 pandemic: interim guidance, 26 March 2020. Mar 2020 [internet publication].Full text

132. Centers for Disease Control and Prevention. Schedule changes during the COVID-19 pandemic. Feb 2021 [internet publication].Full text

133. Public Health England. Statement from Joint Committee on Vaccination and Immunisation on immunisation prioritisation. Apr 2020 [internet publication].Full text

134. Causey K, Fullman N, Sorensen R, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021 Aug 7;398(10299):522-34.Full text  Abstract

135. Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-3.Full text  Abstract

136. Patel Murthy B, Zell E, Kirtland K, et al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations - 10 U.S. jurisdictions, March-September 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840-5.Full text  Abstract

137. American Academy of Pediatrics. Guidance on providing pediatric well-care during COVID-19. Jan 2022 [internet publication].Full text

138. UK Health Security Agency. COVID-19: impact on childhood vaccinations: data to August 2021. Oct 2021 [internet publication].Full text

139. Centers for Disease Control and Prevention. Frequently asked influenza (flu) questions: 2021-2022 season. May 2022 [internet publication].Full text

140. UK Health Security Agency. National flu immunisation programme 2022 to 2023 letter. Apr 2022 [internet publication].Full text

141. Joint Committee of Vaccination and Immunisation: statement on the delivery of the HPV vaccine. Jul 2020 [internet publication].Full text

142. NHS England. Palivizumab passive immunisation against respiratory syncytial virus (RSV) in at-risk pre-term infants. Jul 2021 [internet publication].Full text

143. Anticoagulation Forum. Managing anticoagulation during the COVID-19 pandemic: frequently asked questions. Mar 2020 [internet publication].Full text

144. Medicines and Healthcare Products Regulatory Agency. Warfarin and other anticoagulants - monitoring of patients during the COVID-19 pandemic. Oct 2020 [internet publication].Full text

145. NHS National Patient Safety Alert. Inappropriate anticoagulation of patients with a mechanical heart valve. Jul 2021 [internet publication].Full text

146. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines: antithrombotic therapy in patients with COVID-19. Feb 2022 [internet publication].Full text

147. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. May 2022 [internet publication].Full text

148. Speed V, Patel RK, Byrne R, et al. A perfect storm: root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res. 2020 Aug;192:73-4.Full text  Abstract

149. Handy A, Banerjee A, Wood A, et al. Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart. 10 Mar 2022 [Epub ahead of print].Full text  Abstract

150. Center for the Study of Traumatic Stress. Taking care of patients during the coronavirus outbreak: a guide for psychiatrists. 2020 [internet publication].Full text

151. Substance Abuse and Mental Health Services Administration. Coronavirus (COVID-19). Mar 2022 [internet publication].Full text

152. Royal College of Psychiatrists. COVID-19: providing medication. 2020 [internet publication].Full text

153. Kahl KG, Correll CU. Management of patients with severe mental illness during the coronavirus disease 2019 pandemic. JAMA Psychiatry. 2020 Sep 1;77(9):977-8.Full text  Abstract

154. Yalçın N, Ak S, Demirkan K. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Eur J Hosp Pharm. 2021 Jan;28(1):e2.Full text  Abstract

155. Mental Health Foundation. The COVID-19 pandemic, financial inequality and mental health. May 2020 [internet publication].Full text

156. Vai B, Mazza MG, Delli Colli C, et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021 Sep;8(9):797-812.Full text  Abstract

157. Fond G, Nemani K, Etchecopar-Etchart D, et al. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Nov 1;78(11):1208-17.Full text  Abstract

158. Ceban F, Nogo D, Carvalho IP, et al. Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Oct 1;78(10):1079-91.Full text  Abstract

159. Tzur Bitan D, Kridin K, Dov Cohen A, et al. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study. Lancet Psychiatry. 2021 Oct;8(10):901-8.Full text  Abstract

160. Murphy S, O'Reilly D, Owen R, et al. Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort. Br J Psychiatry. 7 Mar 2022 [Epub ahead of print].Full text  Abstract

161. Czeisler MÉ , Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic — United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69:1049-57.Full text

162. Bryant-Genevier, Rao CY, Lopes-Cardozo B, et al. Symptoms of depression, anxiety, post-traumatic stress disorder, and suicidal ideation among state, tribal, local, and territorial public health workers during the COVID-19 pandemic - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 3;70(48):1680-5.Full text  Abstract

163. Czeisler ME, Board A, Thierry JM, et al. Mental health and substance use among adults with disabilities during the COVID-19 pandemic - United States, February-March 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1142-9.Full text  Abstract

164. Czeisler ME, Rohan EA, Melillo S, et al. Mental health among parents of children aged <18 years and unpaid caregivers of adults during the COVID-19 pandemic - United States, December 2020 and February-⁠March 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):879-87.Full text  Abstract

165. Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020 Sep 1;3(9):e2019686.Full text  Abstract

166. Vahratian A, Blumberg SJ, Terlizzi EP, et al. Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic - United States, August 2020-February 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):490-4.Full text  Abstract

167. Jia H, Guerin RJ, Barile JP, et al. National and state trends in anxiety and depression severity scores among adults during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1427-32.Full text  Abstract

168. Pan KY, Kok AA, Eikelenboom M, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021 Feb;8(2):121-9.Full text  Abstract

169. van der Velden PG, Contino C, Das M, et al. Differences in mental health problems, coping self-efficacy and social support between adults victimised before and adults victimised after the COVID-19 outbreak: population-based prospective study. Br J Psychiatry. 2022 Jan 24:1-7.Full text  Abstract

170. Wong SYS, Zhang D, Sit RWS, et al. Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care. Br J Gen Pract. 2020 Oct 29;70(700):e817-24.Full text  Abstract

171. Zaninotto P, Iob E, Demakakos P, et al. Immediate and longer-term changes in the mental health and well-being of older adults in England during the COVID-19 pandemic. JAMA Psychiatry. 2021 Dec 22;e213749.Full text  Abstract

172. Di Gessa G, Price D. The impact of shielding during the COVID-19 pandemic on mental health: evidence from the English Longitudinal Study of Ageing. Br J Psychiatry. 4 Apr 2022 [Epub ahead of print].Full text  Abstract

173. Wilke J, Hollander K, Mohr L, et al. Drastic reductions in mental well-being observed globally during the COVID-19 pandemic: results from the ASAP survey. Front Med (Lausanne). 2021 Mar 26;8:578959.Full text  Abstract

174. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700-12.Full text  Abstract

175. Iob E, Steptoe A, Fancourt D. Abuse, self-harm and suicidal ideation in the UK during the COVID-19 pandemic. Br J Psychiatry. 2020 Oct;217(4):543-6.Full text  Abstract

176. Office for Health Improvement and Disparities. COVID-19: mental health and wellbeing surveillance report. Important findings so far. Apr 2022 [internet publication].Full text

177. O'Connor RC, Wetherall K, Cleare S, et al. Mental health and wellbeing during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 mental health & wellbeing study. Br J Psychiatry. 2020 Oct 21:1-17 [internet publication].Full text  Abstract

178. Pierce M, McManus S, Hope H, et al. Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data. Lancet Psychiatry. 2021 Jul;8(7):610-9.Full text  Abstract

179. Di Gessa G, Maddock J, Green MJ, et al. Pre-pandemic mental health and disruptions to healthcare, economic, and housing outcomes during COVID –19: evidence from 12 UK longitudinal studies. Br J Psychiatry. 2021:1-10.Full text

180. Das-Munshiabe J, Chang CK, Bakolisf I, et al. All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study. Lancet Reg Health Eur. 2021 Dec;11:100228.Full text

181. Carr MJ, Steeg S, Webb RT, et al. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public Health. 2021 Feb;6(2):e124-35.Full text  Abstract

182. Wathelet M, Duhem S, Vaiva G, et al. Factors associated with mental health disorders among university students in France confined during the COVID-19 pandemic. JAMA Netw Open. 2020 Oct 1;3(10):e2025591.Full text  Abstract

183. Raina P, Wolfson C, Griffith L, et al. A longitudinal analysis of the impact of the COVID-19 pandemic on the mental health of middle-aged and older adults from the Canadian longitudinal study on aging. Nature Aging. 2021;1:1137–47.Full text

184. Pirkis J, John A, Shin S, et al. Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries. Lancet Psychiatry. 2021 Jul;8(7):579-88.Full text  Abstract

185. Grocke-Dewey M, Hardison-Moody A, Haynes-Maslow L, et al. Examining the relationship between physical activity and mental health during the COVID-19 pandemic across five U.S. States. Prev Med Rep. 2021 Dec;24:101537.Full text  Abstract

186. Oka T, Kubo T, Kobayashi N, et al. Multiple time measurements of multidimensional psychiatric states from immediately before the COVID-19 pandemic to one year later: a longitudinal online survey of the Japanese population. Transl Psychiatry. 2021 Nov 11;11(1):573.Full text  Abstract

187. Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022 Feb 16;376:e068993.Full text  Abstract

188. The Childhood Trust. Children in lockdown: the consequences of the coronavirus crisis for children living in poverty. Jun 2020 [internet publication].Full text

189. American Academy of Pediatrics. Interim guidance on supporting the emotional and behavioral health needs of children, adolescents, and families during the COVID-19 pandemic. Dec 2021 [internet publication].Full text

190. Bignardi G, Dalmaijer ES, Anwyl-Irvine AL, et al. Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown. Arch Dis Child. 2020 Dec 9;106(8):791-7.Full text  Abstract

191. Loades ME, Chatburn E, Higson-Sweeney N, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1218-39.Full text  Abstract

192. Rider EA, Ansari E, Varrin PH, et al. Mental health and wellbeing of children and adolescents during the covid-19 pandemic. BMJ. 2021 Aug 24;374:n1730.Full text  Abstract

193. NHS Digital. Mental health of children and young people in England, 2020: wave 1 follow up to the 2017 survey. Oct 2020 [internet publication].Full text

194. Robinson J. Peaks in number of young people prescribed antidepressants coincide with lockdowns. PJ. 2021 Jun;306(7950):306.Full text

195. Thorisdottir IE, Asgeirsdottir B, Kristjansson AL, et al. Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study. Lancet Psychiatry. 2021 Aug;8(8):663-72.Full text  Abstract

196. Leeb RT, Bitsko RH, Radhakrishnan L, et al. Mental health-related emergency department visits among children aged <18 years during the COVID-19 pandemic - United States, January 1-October 17, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1675-80.Full text  Abstract

197. Radhakrishnan L, Leeb RT, Bitsko RH, et al. Pediatric emergency department visits associated with mental health conditions before and during the COVID-19 pandemic - United States, January 2019-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):319-24.Full text  Abstract

198. Yard E, Radhakrishnan L, Ballesteros MF, et al. Emergency department visits for suspected suicide attempts among persons aged 12-25 years before and during the COVID-19 pandemic - United States, January 2019-May 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):888-94.Full text  Abstract

199. Charpignon ML, Ontiveros J, Sundaresan S, et al. Evaluation of suicides among US adolescents during the COVID-19 pandemic. JAMA Pediatr. 25 Apr 2022 [Epub ahead of print].Full text  Abstract

200. Jones SE, Ethier KA, Hertz M, et al. Mental health, suicidality, and connectedness among high school students during the COVID-19 pandemic - adolescent behaviors and experiences survey, United States, January-June 2021. MMWR Suppl. 2022 Apr 1;71(3):16-21.Full text  Abstract

201. American Academy of Pediatrics. AAP-AACAP-CHA declaration of a national emergency in child and adolescent mental health. Oct 2021 [internet publication].Full text

202. Verlenden J, Pampati S, Rasberry C, et al. Association of children’s mode of school instruction with child and parent experiences and well-being during the COVID-19 pandemic — COVID Experiences Survey, United States, October 8-November 13, 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):369-76.Full text  Abstract

203. Kisely S, Warren N, McMahon L, et al. Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis. BMJ. 2020 May 5;369:m1642.Full text  Abstract

204. Schwartz R, Sinskey JL, Anand U, et al. Addressing postpandemic clinician mental health : a narrative review and conceptual framework. Ann Intern Med. 2020 Dec 15;173(12):981-8.Full text  Abstract

205. Barello S, Palamenghi L, Graffigna G. Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res. 2020 Aug;290:113129.Full text  Abstract

206. NHS England. NHS staff survey results. 2020 [internet publication].Full text

207. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): coping with stress. Mar 2022 [internet publication].Full text

208. Centers for Disease Control and Prevention. Emergency responders: tips for taking care of yourself. Mar 2018 [internet publication].Full text

209. World Health Organization. WHO briefing note: mental health and psychosocial considerations during the COVID-19 outbreak. Mar 2020 [internet publication].Full text

210. National Institute for Health and Care Excellence. COVID-19 rapid guideline: children and young people who are immunocompromised. Aug 2020 [internet publication].Full text

211. Rosenthal CM, Thompson LA. Child abuse awareness month during the coronavirus disease 2019 pandemic. JAMA Pediatr. 2020 Aug 1;174(8):812.Full text  Abstract

212. Sidpra J, Abomeli D, Hameed B, et al. Rise in the incidence of abusive head trauma during the COVID-19 pandemic. Arch Dis Child. 2021 Mar;106(3):e14.Full text  Abstract

213. American Academy of Pediatrics. Caring for children and youth with special health care needs during the COVID-19 pandemic. Feb 2022 [internet publication].Full text

214. Klein JD, Koletzko B, El-Shabrawi MH, et al. Promoting and supporting children's health and healthcare during COVID-19 - International Paediatric Association position statement. Arch Dis Child. 2020 Jul;105(7):620-4.Full text  Abstract

215. Royal College of Paediatrics and Child Health. Safeguarding, looked after children and vulnerable children processes in England, Wales and Northern Ireland. Apr 2021 [internet publication].Full text

216. Medicines and Healthcare Products Regulatory Agency (UK). Valproate pregnancy prevention programme: temporary advice for management during coronavirus (COVID-19). May 2020 [internet publication].Full text

217. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020 May 26;141(21):e823-31.Full text  Abstract

218. Zaman S, MacIsaac AI, Jennings GLR, et al. Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement. Med J Aust. 2020 Apr 3;213(4):182-7.Full text  Abstract

219. Kumar S, Haqqani H, Wynn G, et al. Position statement on the management of cardiac electrophysiology and cardiac Implantable electronic devices in Australia during the COVID-19 pandemic: a living document. Heart, Lung and Circulation. 2020 Jun 01;29(6):E57-68.Full text

220. Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-103.Full text  Abstract

221. Association of Laparoscopic Surgeons of Great Britain and Northern Ireland. Laparoscopy in the COVID-19 environment - ALSGBI position statement. Apr 2020 [internet publication].Full text

222. Pavan N, Crestani A, Abrate A, et al. Risk of virus contamination through surgical smoke during minimally invasive surgery: a systematic review of the literature on a neglected issue revived in the COVID-19 pandemic era. Eur Urol Focus. 2020 Sep 15;6(5):1058-69.Full text  Abstract

223. de Leeuw RA, Burger NB, Ceccaroni M, et al. COVID-19 and laparoscopic surgery: scoping review of current literature and local expertise. JMIR Public Health Surveill. 2020 Jun 23;6(2):e18928.Full text  Abstract

224. Collings AT, Jeyarajah DR, Hanna NM, et al. SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19. Surg Endosc. 2022 May;36(5):2723-33.Full text  Abstract

225. Siah KTH, Rahman MM, Ong AML, et al. The practice of gastrointestinal motility laboratory during COVID-19 pandemic: position statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 position statements). J Neurogastroenterol Motil. 2020 Jul 30;26(3):299-310.Full text  Abstract

226. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rearranging planned care in hospitals and diagnostic services. Jul 2020 [internet publication].Full text

227. El-Boghdadly K, Cook TM, Goodacre T, et al. Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England. Anaesthesia. 22 Feb 2022 [Epub ahead of print].Full text  Abstract

228. Royal College of Surgeons of England. Recovery of surgical services during and after COVID-19. May 2020 [internet publication].Full text

229. American College of Surgeons. Clinical issues and guidance. Jul 2021 [internet publication].Full text

230. Mouton C, Hirschmann MT, Ollivier M, et al. COVID-19 - ESSKA guidelines and recommendations for resuming elective surgery. J Exp Orthop. 2020 May 13;7(1):28.Full text  Abstract

231. Parvizi J, Gehrke T, Krueger CA, et al. Resuming elective orthopaedic surgery during the COVID-19 pandemic: guidelines developed by the International Consensus Group (ICM). J Bone Joint Surg Am. 2020 Jul 15;102(14):1205-12.Full text  Abstract

232. Shah PB, Welt FGP, Mahmud E, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. JACC Cardiovasc Interv. 2020 Jun 22;13(12):1484-8.Full text  Abstract

233. Hands K, Taylor C, Kotzé A, et al. Preoperative patient blood management during the SARS-CoV-2 pandemic. Br J Haematol. 2021 Jun;193(6):1087-92.Full text  Abstract

234. American College of Surgeons. COVID-19 guidelines for triage of emergency general surgery patients. Dec 2020 [internet publication].Full text

235. NELA Project Team. The impact of COVID-19 on emergency laparotomy – an interim report of the national emergency laparotomy audit, 23 March 2020 – 30 September 2020. London: Royal College of Anaesthetists, 2021.Full text

236. COVIDSurg Collaborative. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg. 2021 Nov 11;108(11):1274-92.Full text  Abstract

237. Royal College of Psychiatrists. COVID-19: eating disorder services. 2020 [internet publication].Full text

238. American Academy of Pediatrics. Obesity management and treatment during COVID-19. Sep 2021 [internet publication].Full text

239. Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020 Jul;183(1):G33-9.Full text  Abstract

240. Jeffery MM, D'Onofrio G, Paek H, et al. Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US. JAMA Intern Med. 2020 Oct 1;180(10):1328-33.Full text  Abstract

241. Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020 Jun 5;324(1):96-9.Full text  Abstract

242. Radhakrishnan L, Carey K, Hartnett KP, et al. Pediatric emergency department visits before and during the COVID-19 pandemic - United States, January 2019-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):313-8.Full text  Abstract

243. Bodilsen J, Brønnum Nielsen P, Søgaard M, et al. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study. BMJ. 2021 May 24;373:n1135.Full text  Abstract

244. Farrow L, Gardner W, Tang C, et al. Impact of COVID-19 on opioid use in those awaiting hip and knee arthroplasty: a retrospective cohort study. BMJ Qual Saf. 14 Sep 2021 [Epub ahead of print].Full text  Abstract

245. Williams R, Jenkins DA, Ashcroft DM, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. Lancet Public Health. 2020 Oct;5(10):e543-50.Full text  Abstract

246. Topriceanu CC, Wong A, Moon JC, et al. Evaluating access to health and care services during lockdown by the COVID-19 survey in five UK national longitudinal studies. BMJ Open. 2021 Mar 18;11(3):e045813.Full text  Abstract

247. Royal College of Paediatrics and Child Health. Advice for parents during coronavirus. 2021 [internet publication].Full text

248. Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020 Aug 8;396(10248):381-9.Full text  Abstract

249. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020 Dec;106(23):1805-11.Full text  Abstract

250. Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021 Jan;107(2):113-9.Full text  Abstract

251. Solomon MD, Nguyen-Huynh M, Leong TK, et al. Changes in patterns of hospital visits for acute myocardial infarction or ischemic stroke during COVID-19 surges. JAMA. 2021 Jul 6;326(1):82-4.Full text  Abstract

252. Wadhera R, Figueroa JF, Rodriguez F, et al. Racial and ethnic disparities in heart and cerebrovascular disease deaths during the COVID-19 pandemic in the United States. Circulation. 2021 Jun 15;143(24):2346-54.Full text  Abstract

253. Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health. 2020 Oct;5(10):e536-42.Full text  Abstract

254. Mohammad MA, Koul S, Olivecrona GK, et al. Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. Heart. Oct 2020 [internet publication].Full text  Abstract

255. Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart. 2020 Dec 17 [Epub ahead of print].Full text  Abstract

256. Holt A, Gislason GH, Schou M, et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020 Jun 1;41(32):3072-9.Full text  Abstract

257. You Y, Niu Y, Sun F, et al. Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis. BMJ Open. 2021 Dec 14;11(12):e050559.Full text  Abstract

258. Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020 Aug 25;324(8):801-4.Full text  Abstract

259. Rabbone I, Schiaffini R, Cherubini V, et al. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020 Nov;43(11):2870-2.Full text  Abstract

260. Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020 Nov;43(11):e170-1.Full text  Abstract

261. Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021 Jul;9(7):413-5.Full text  Abstract

262. Misra S, Barron E, Vamos E, et al. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-80.Full text  Abstract

263. Patel SY, McCoy RG, Barnett ML, et al. Diabetes care and glycemic control during the COVID-19 pandemic in the United States. JAMA Intern Med. 2021 Oct 1;181(10):1412-4.Full text  Abstract

264. Hatoun J, Correa ET, Donahue SMA, et al. Social distancing for COVID-19 and diagnoses of other infectious diseases in children. Pediatrics. 2020 Oct;146(4):e2020006460.Full text  Abstract

265. Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic — United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-9.Full text  Abstract

266. Kadambari S, Goldacre R, Morris E, et al. Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study. BMJ. 2022 Jan 12;376:e067519.Full text  Abstract

267. Fakih MG, Bufalino A, Sturm L, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol. 2022 Jan;43(1):26-31.Full text  Abstract

268. Ray LC, Collins JP, Griffin PM, et al. Decreased incidence of infections caused by pathogens transmitted commonly through food during the COVID-19 pandemic - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2017-2020. MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1332-6.Full text  Abstract

269. Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 Sep;8(9):e1132-41.Full text  Abstract

270. Kaufman HW, Chen Z, Niles J, et al. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020 Aug 3;3(8):e2017267.Full text  Abstract

271. Patt D, Gordan L, Diaz M, et al. The impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. Oct 2020 [internet publication].Full text

272. Centers for Disease Control and Prevention. Sharp declines in breast and cervical cancer screening. Jun 2021 [internet publication].Full text

273. Lai AG, Pasea L, Banerjee A, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020 Nov 17;10(11):e043828.Full text  Abstract

274. Morris EJA, Goldacre R, Spata E, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):199-208.Full text  Abstract

275. COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-17.Full text  Abstract

276. Bofill Rodriguez M, Lethaby A, Farquhar C, et al. Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2020 Jul 23;7:CD013651.Full text  Abstract

277. Medicines and Healthcare products Regulation Agency. Coronavirus vaccine - weekly summary of Yellow Card reporting. Apr 2022 [internet publication].Full text

278. Royal College of Obstetricians and Gynaecologists. RCOG/FSRH respond to reports of 30,000 women’s periods affected after COVID-19 vaccine. Sep 2021 [internet publication].Full text

279. Medicines and Healthcare products Regulatory Agency. COVID-19 vaccines: updates for August 2021. Aug 2021 [internet publication].Full text

280. Campanile FC, Podda M, Arezzo A, et al. Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement. World J Emerg Surg. 2020 Jun 8;15(1):38.Full text  Abstract

281. Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020 Nov 10;10(11):e042573.Full text  Abstract

282. Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021 Mar 1;4(3):e211095.Full text  Abstract

283. Nephrology Journal Club. Acute kidney injury. Mar 2020 [internet publication].Full text

284. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dialysis service delivery. Sep 2020 [internet publication].Full text

285. Zeidan AM, Boddu PC, Patnaik MM, et al. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol. 2020 Aug;7(8):e601-12.Full text  Abstract

286. American Society of Hematology. COVID-19 and adult ALL: frequently asked questions. Jan 2021 [internet publication].Full text

287. Maneikis K, Šablauskas K, Ringelevičiūtė U, et al. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021 Aug;8(8):e583-92.Full text  Abstract

288. Sun C, Pleyer C, Wiestner A. COVID-19 vaccines for patients with haematological conditions. Lancet Haematol. 2021 May;8(5):e312-4.Full text  Abstract

289. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-45.Full text  Abstract

290. National Cancer Research Institute Acute Myelogenous Leukaemia working party. Recommendations for the management of patients with AML during the COVID-19 outbreak. Oct 2020 [internet publication].Full text

291. Arlt W, Baldeweg SE, Pearce SHS, et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. 2020 Jul;183(1):G25-32.Full text  Abstract

292. British Society for Allergy and Immunology. Modifications for adult allergy services during the COVID-19 pandemic. Apr 2020 [internet publication].Full text

293. Cardinale F, Ciprandi G, Barberi S, et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr. 2020 Jun 16;46(1):84.Full text  Abstract

294. Shah BN, Schlosshan D, McConkey HZR, et al. Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care. Heart. 2020 Oct;106(20):1549-54.Full text  Abstract

295. American Society of Hematology. COVID-19 and aplastic anemia: frequently asked questions. May 2021 [internet publication].Full text

296. European Society for Blood and Marrow Transplantation. COVID-19 - bone marrow failure and PNH recommendations on behalf of the Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT). Mar 2020 [internet publication].Full text

297. NHS England. Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults) (RPS 2006). Dec 2021 [internet publication].Full text

298. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2022. [internet publication].Full text

299. Dolby T, Nafilyan V, Morgan A, et al. Relationship between asthma and severe COVID-19: a national cohort study. Thorax. 30 Mar 2022 [Epub ahead of print].Full text  Abstract

300. Shi T, Pan J, Vasileiou E, et al. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study. Lancet Respir Med. 2022 Apr;10(4):347-54.Full text  Abstract

301. Bloom C, Drake T, Docherty A, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021 Jul;9(7):699-711.Full text  Abstract

302. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 Aug;9(8):909-23.Full text  Abstract

303. National Institute for Health and Care Excellence. COVID-19 rapid guideline: severe asthma. Apr 2020 [internet publication].Full text

304. Licskai C, Yang CL, Ducharme FM, et al. Addressing therapeutic questions to help Canadian physicians optimize asthma management for their patients during the COVID-19 pandemic. Can J Resp Crit Care Sleep Med. 2020 Apr 30;4(2):73-6.Full text

305. American Lung Association. Asthma and COPD mythbusting with Dr. Juanita Mora. Mar 2020 [internet publication].Full text

306. European Lung Foundation. COVID-19 and lung disease Q&A. Mar 2021 [internet publication].Full text

307. Centers for Disease Control and Prevention. Clinical questions about COVID-19: questions and answers. Apr 2022 [internet publication].Full text

308. Houston SA, McDonald CM, Tyan CC, et al. Bronchoscopy during the COVID-19 pandemic: a Canadian Thoracic Society position statement. Jun 2021 [internet publication].Full text

309. British Thoracic Society. Advice for healthcare professionals treating people with asthma (adults) in relation to COVID-19. Nov 2020 [internet publication].Full text

310. Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc. 2020 Dec;17(12):1645-8.Full text  Abstract

311. Davies GA, Alsallakh MA, Sivakumaran S, et al. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021 Sep;76(9):867-73.Full text  Abstract

312. Shah SA, Quint JK, Nwaru BI, et al. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021 Sep;76(9):860-66.Full text  Abstract

313. Cortese S, Asherson P, Sonuga-Barke E, et al. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health. 2020 Jun;4(6):412-14.Full text  Abstract

314. British Society of Gastroenterology. A joint statement on vaccination for Sars-CoV-2 in patients with liver disease. Mar 2021 [internet publication].Full text

315. American Society of Breast Surgeons. Recommendations for prioritization, treatment and triage of patients with breast cancer during the COVID-19 pandemic. Apr 2020 [internet publication].Full text

316. Association of Breast Surgery. Recommendations on delivery of breast services during the COVID-19 pandemic. May 2020 [internet publication].Full text

317. Association of Breast Surgery and UK Breast Cancer Group. Joint statement on neoadjuvant chemotherapy during the COVID-19 pandemic. May 2020 [internet publication].Full text

318. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. 2021 Oct;217(4):831-4.Full text  Abstract

319. Robinson KA, Maimone S, Gococo-Benore DA, et al. Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA Oncol. 2021 Sep 1;7(9):1395-7.Full text  Abstract

320. Royal College of Paediatrics and Child Health. National guidance for the management of children with bronchiolitis and lower respiratory tract infections during COVID-19. Dec 2021 [internet publication].Full text

321. UK and Ireland Neuroendocrine Tumour Society. COVID-19 pandemic strategy for the interim management of patients with neuroendocrine tumours/neuroendocrine cancer. Apr 2020 [internet publication].Full text

322. International Liaison Committee on Resuscitation. COVID-19: practical guidance for implementation. 2020 [internet publication].Full text

323. Resuscitation Council UK. Resuscitation Council UK statement on COVID-19 in relation to CPR and resuscitation in acute hospital settings. Aug 2021 [internet publication].Full text

324. Hsu A, Sasson C, Kudenchuk PJ, et al. 2021 Interim guidance to health care providers for basic and advanced cardiac life support in adults, children, and neonates with suspected or confirmed COVID-19. Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008396.Full text  Abstract

325. Resuscitation of the drowned person in the era of COVID-19 disease: a common ground for recommendations, identification of research needs and a global call to action. Position statement of the International Drowning Researchers' Alliance, International Life Saving Federation Medical Committee and International Maritime Rescue Federation. May 2020 [internet publication].Full text

326. Position Statement: cardiopulmonary resuscitation of patients with confirmed or suspected COVID-19 - 2020. Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Society of Cardiology (SBC), Brazilian Association of Intensive Care Medicine (AMIB), and Brazilian Society of Anesthesiology (SBA). Jul 2020 [internet publication].Full text

327. Trovato CM, Montuori M, Cucchiara S, et al. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1523-6.Full text  Abstract

328. Manto M, Dupre N, Hadjivassiliou M, et al. Management of patients with cerebellar ataxia during the COVID-19 pandemic: current concerns and future implications. Cerebellum. 2020 Aug;19(4):562-8.Full text  Abstract

329. Royal College of Obstetricians and Gynaecologists. Guidance for maternal medicine services in the coronavirus (COVID-19) pandemic. Dec 2020 [internet publication].Full text

330. Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19), pregnancy and women’s health. 2021 [internet publication].Full text

331. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers. Lancet. 2019 Mar 2;393(10174):899-909.Full text  Abstract

332. Yonas E, Alwi I, Pranata R, et al. Effect of heart failure on the outcome of COVID-19: a meta analysis and systematic review. Am J Emerg Med. 2020 Jul 9 [Epub ahead of print].Full text  Abstract

333. Bhatt AS, Jering KS, Vaduganathan M, et al. Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 2021 Jan;9(1):65-73.Full text  Abstract

334. CAPACITY-COVID Collaborative Consortium and LEOSS Study Group. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J. 2022 Mar 14;43(11):1104-20.Full text  Abstract

335. Rey JR, Caro-Codón J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. 2020 Dec;22(12):2205-15.Full text  Abstract

336. Centers for Disease Control and Prevention. COVID-19: people at increased risk and other people who need to take extra precautions. Mar 2022 [internet publication].Full text

337. Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020 Jul 13;12(13):12493-503.Full text  Abstract

338. Svensson P, Hofmann R, Häbel H, et al. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021 Feb 17;11(2):e044486.Full text  Abstract

339. Biswas M, Rahaman S, Biswas TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 9 Dec 2020 [Epub ahead of print].Full text  Abstract

340. National Institute for Health and Care Excellence. COVID-19 rapid guideline: chronic kidney disease. May 2020 [internet publication].Full text

341. Carr EJ, Wu M, Harvey R, et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 Sep 18;398(10305):1038-41.Full text  Abstract

342. Sibbel S, McKeon K, Luo J, et al. Real-world effectiveness and immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 vaccines in patients on hemodialysis. J Am Soc Nephrol. 2022 Jan;33(1):49-57.Full text  Abstract

343. Hsu CM, Weiner DE, Manley HJ, et al. Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months. Clin J Am Soc Nephrol. 2022 Mar;17(3):403-13.Full text  Abstract

344. Shen Q, Wang M, Che R, et al. Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol. 2020 Jul;35(7):1351-57.Full text  Abstract

345. Scarfò L, Chatzikonstantinou T, Rigolin GM, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020 Sep;34(9):2354-63.Full text  Abstract

346. American Society of Hematology. COVID-19 and CLL: frequently asked questions. Feb 2021 [internet publication].Full text

347. Di Ciaccio P, McCaughan G, Trotman J, et al. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Intern Med J. 2020 Jun;50(6):667-79.Full text  Abstract

348. Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021 Jun 10;137(23):3165-73.Full text  Abstract

349. American Society of Hematology. COVID-19 and CML: frequently asked questions. Sep 2021 [internet publication].Full text

350. Noor FM, Islam M. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health. 2020 Dec;45(6):1270-82.Full text  Abstract

351. Rabbani G, Shariful Islam SM, Rahman MA, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021 Jan 7;1-12.Full text  Abstract

352. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2022 report. Dec 2021 [internet publication].Full text

353. National Institute for Health and Care Excellence. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). Apr 2020 [internet publication].Full text

354. British Thoracic Society. COPD and COVID-19 for healthcare professionals. Apr 2020 [internet publication].Full text

355. British Thoracic Society. Pulmonary rehabilitation resource pack. Jun 2021 [internet publication].Full text

356. Tan JY, Conceicao EP, Wee LE, et al. COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax. 2021 May;76(5):512-3.Full text  Abstract

357. Shanthanna H, Strand NH, Provenzano DA, et al. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020 Jul;75(7):935-44.Full text  Abstract

358. Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021 Jul;3(7):e498-506.Full text

359. Tuan WJ, Spotts H, Zgierska AE, et al. COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study. BMJ Open. 2021 Nov 26;11(11):e056436.Full text  Abstract

360. Bosworth ML, Ayoubkhani D, Nafilyan V, et al. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study. Lancet Public Health. 2021 Nov;6(11):e817-25.Full text  Abstract

361. Klimek L, Jutel M, Bousquet J, et al. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - An EAACI position paper. Allergy. 2021 Mar;76(3):677-88.Full text  Abstract

362. Große K, Kramer M, Trautwein C, et al. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure. Liver Int. 2020 Jul;40(7):1792-3.Full text  Abstract

363. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010 May;85(5):451-8.Full text  Abstract

364. Marjot T, Webb GJ, Barritt AS, et al. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-8.Full text  Abstract

365. John BV, Deng Y, Scheinberg A, et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021 Oct 1;181(10):1306-14.Full text  Abstract

366. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19. Mar 2020 [internet publication].Full text

367. Centre for Evidence-Based Medicine. Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video. Apr 2020 [internet publication].Full text

368. Centers for Disease Control and Prevention. Fungal diseases and COVID-19. Mar 2022 [internet publication].Full text

369. Alsaied T, Aboulhosn JA, Cotts TB, et al. Coronavirus disease 2019 (COVID-19) pandemic implications in pediatric and adult congenital heart disease. J Am Heart Assoc. 2020 Jun 16;9(12):e017224.Full text  Abstract

370. Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021 May 14;42(19):1858-65.Full text  Abstract

371. Radke RM, Frenzel T, Baumgartner H, et al. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302-09.Full text

372. Faculty of Sexual and Reproductive Healthcare. FSRH CEU advice to support the provision of effective contraception during the COVID-19 outbreak. Mar 2020 [internet publication].Full text

373. Royal College of Obstetricians and Gynecologists, Faculty of Sexual and Reproductive Healthcare, and British Society of Abortion Care Providers Joint Guidance. Coronavirus (COVID-19) infection and abortion care. Jul 2020 [internet publication].Full text

374. Department of Health and Social Care. England to return to pre-pandemic system for early abortions. 24 February 2022 [internet publication].Full text

375. Ricciuto A, Lamb C, Benchimol E, et al. Inflammatory bowel disease clinical activity is associated with COVID-19 severity especially in younger patients. J Crohns Colitis. 2022 May 10;16(4):591-600.Full text  Abstract

376. British Society of Gastroenterology. Expanded consensus advice for the management of IBD during the COVID-19 pandemic. Mar 2021 [internet publication].Full text

377. Quraishi MN, Cooney R, Brookes MJ, et al. An urgent need to institute COVID-19 testing in patients with IBD experiencing flares. Front Gastroenterol. 2020 Mar 27;11(4):330-1.Full text  Abstract

378. Zingone F, Savarino EV. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525.Full text  Abstract

379. International Organization for the Study of Inflammatory Bowel Disease. Care of the IBD patient requiring hospitalization or surgery during the COVID-19 pandemic. May 2020 [internet publication].Full text

380. International Organisation for the study of inflammatory bowel disease. IOIBD recommendations: best practice guidance for when to restart IBD therapy in patients who have suspected or confirmed COVID-19. May 2020 [internet publication].Full text

381. Kennedy N, Goodhand JR, Bewshea C, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 May;70(5):865-75.Full text  Abstract

382. American Gastroenterological Association. Gastroenterology professional society guidance on endoscopic procedures during the COVID-19 pandemic. Mar 2020 [internet publication].Full text

383. Iacucci M, Cannatelli R, Labarile N, et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606.Full text  Abstract

384. Remzi FH, Panis Y, Spinelli A, et al. International Organization for the Study of Inflammatory Bowel Disease recommendations for surgery in patients with inflammatory bowel disease during the COVID-19 pandemic. Dis Colon Rectum. 2020 Jul;63(7):870-3.Full text  Abstract

385. British Society of Gastroenterology. BSG inflammatory bowel disease section and clinical research group position statement on SARS-CoV2 vaccination. Sep 2021 [internet publication].Full text

386. Alexander JL, Kennedy NA, Ibraheim H, et al. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):342-52.Full text  Abstract

387. Syversen SW, Jyssum I, Tveter AT, et al. Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients on immunosuppressive therapy. Arthritis Rheumatol. 4 May 2022 [Epub ahead of print].Full text  Abstract

388. Sperger J, Shah K, Lu M, et al. Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients. BMJ Open. 2021 Nov 12;11(11):e049740.Full text  Abstract

389. Newell-Price J, Nieman L, Reincke M, et al. Endocrinology in the time of COVID-19: management of Cushing's syndrome. Eur J Endocrinol. 2020 Jul;183(1):G1-7.Full text  Abstract

390. Pivonello R, Ferrigno R, Isidori A, et al. COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-6.Full text  Abstract

391. Papadavid E, Scarisbrick J, Ortiz Romero P, et al. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-6.Full text  Abstract

392. National Institute for Health and Care Excellence. COVID-19 rapid guideline: cystic fibrosis. Oct 2020 [internet publication].Full text

393. Wang Q, Davis PB, Gurney ME, et al. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021 Aug;17(8):1297-306.Full text  Abstract

394. European Academy of Neurology. Dementia Scientific Panel report - COVID-19. Apr 2020 [internet publication].Full text

395. Livingston G, Rostamipour H, Gallagher P, et al. Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study. Lancet Psychiatry. 2020 Dec;7(12):1054-63.Full text  Abstract

396. McGurnaghan SJ, Weir A, Bishop J, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93.Full text  Abstract

397. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021 Feb;44(2):526-32.Full text  Abstract

398. Longmore DK, Miller JE, Bekkering S, et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care. 2021 Jun;44(6):1281-90.Full text  Abstract

399. Barrett CE, Park J, Kompaniyets L, et al. Intensive care unit admission, mechanical ventilation, and mortality among patients with type 1 diabetes hospitalized for COVID-19 in the U.S. Diabetes Care. 2021 Aug;44(8):1788-96.Full text  Abstract

400. Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews. Diabetes Care. 2021 Dec;44(12):2790-811.Full text  Abstract

401. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-33.Full text  Abstract

402. Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021 Jul;64(7):1480-91.Full text  Abstract

403. Wong R, Hall M, Vaddavalli R, et al. Glycemic control and clinical outcomes in U.S. patients with COVID-19: data from the National COVID Cohort Collaborative (N3C) database. Diabetes Care. 24 Feb 2022 [Epub ahead of print].Full text  Abstract

404. Mahamat-Saleh Y, Fiolet T, Rebeaud M, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021 Oct 25;11(10):e052777.Full text  Abstract

405. Bae S, Kim SR, Kim MN, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021 Mar;107(5):373-80.Full text  Abstract

406. Association of British Clinical Diabetologists. Concise advice on inpatient diabetes during COVID19 - front door guidance. Nov 2020 [internet publication].Full text

407. Coppelli A, Giannarelli R, Aragona M, et al. Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care. 2020 Oct;43(10):2345-8.Full text  Abstract

408. Klonoff DC, Messler JC, Umpierrez GE, et al. Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis. Diabetes Care. 2021 Feb;44(2):578-85.Full text  Abstract

409. American Diabetes Association. COVID-19: if you do get sick, know what to do. Mar 2020 [internet publication].Full text

410. Diabetes and Primary Care. At a glance fact sheet: COVID-19 and diabetes. Apr 2020 [internet publication].Full text

411. Sathish T, Kapoor N, Cao Y, et al. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021 Mar;23(3):870-4.Full text  Abstract

412. Barrett C, Koyama A, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65.Full text  Abstract

413. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-50.Full text  Abstract

414. National Inpatient Diabetes Covid-19 Response Group. COncise adVice on Inpatient Diabetes (COVID:Diabetes): dexamethasone/glucocorticosteroid therapy in Covid-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Nov 2020 [internet publication].Full text

415. Dennis JM, Mateen BA, Sonabend R, et al. Type 2 diabetes and COVID-19-related mortality in the critical care setting: a national cohort study in England, March-July 2020. Diabetes Care. 2020 Oct 23:dc201444.Full text  Abstract

416. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020 Jul;43(7):1399-407.Full text  Abstract

417. Mirani M, Favacchio G, Carrone F, et al. Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care. Oct 2020 [internet publication].Full text  Abstract

418. Wander PL, Lowy E, Beste LA, et al. Prior glucose-lowering medication use and 30-day outcomes among 64,892 veterans with diabetes and COVID-19. Diabetes care. 2021 Dec;44(12):2708-13.Full text  Abstract

419. Agarwal S, Schechter C, Southern W, et al. Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and coronavirus disease 2019. Diabetes Care. 2020 Oct;43(10):2339-44.Full text  Abstract

420. Yang W, Sun X, Zhang J, et al. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Diabetes Res Clin Pract. 22 Jun 2021 [Epub ahead of print].Full text  Abstract

421. Ganesh A, Randall MD. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis. Br J Clin Pharmacol. 4 Feb 2022 [Epub ahead of print].Full text  Abstract

422. Patoulias D, Doumas M. Dipeptidyl peptidase-4 inhibitors and COVID-19-related deaths among patients with type 2 diabetes mellitus: a meta-analysis of observational studies. Endocrinol Metab (Seoul). 2021 Aug;36(4):904-8. Abstract

423. Kahkoska AR, Abrahamsen TJ, Alexander GC, et al. Association between glucagon-like peptide 1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use and COVID-19 outcomes. Diabetes Care. 2021 Jul;44(7):1564-72.Full text  Abstract

424. Hariyanto TI, Intan D, Hananto JE, et al. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): a systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2021 Sep;179:109031.Full text  Abstract

425. Steenblock C, Schwarz PE, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-98.Full text  Abstract

426. British Association of Dermatologists. Covid-19 (Coronavirus): statement on dry skin and frequent handwashing to reduce Covid-19 risk. Mar 2020 [internet publication].Full text

427. Leonardi M, Hummelshoj L, Johnson N. Advice regarding COVID-19 and endometriosis for patients and healthcare providers. May 2020 [internet publication].Full text

428. European Academy of Neurology. Impact of COVID-19 on management of epilepsy. Apr 2020 [internet publication].Full text

429. European Reference Network for Rare or Low Prevalence Complex Diseases. COVID-19 and epilepsy - ERN EpiCARE recommendations. Apr 2020 [internet publication].Full text

430. Alsagaff MY, Mulia EPB, Maghfirah I, et al. Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis. Diabetes Metab Syndr. Sep-Oct 2021;15(5):102210.Full text  Abstract

431. British Society for Allergy and Clinical Immunology. Modifications for paediatric allergy services during COVID-19 pandemic. Mar 2020 [internet publication].Full text

432. Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy. 2020 Jul;75(7):1546-54.Full text  Abstract

433. Mackie SL, Brouwer E, Conway R, et al. Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. Lancet Rheumatol. 2021 Jan;3(1):e71-82.Full text  Abstract

434. NHS England. Tocilizumab for giant cell arteritis (GCA) during the COVID-19 pandemic (RPS 2007). Jul 2021 [internet publication].Full text

435. American College of Rheumatology. COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases (RMDs). Feb 2022.Full text  Abstract

436. Landewé RBM, Kroon FPB, Alunno A, et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann Rheum Dis. 23 Feb 2022 [Epub ahead of print].Full text  Abstract

437. National Institute for Health and Care Excellence. COVID-19 rapid guideline: haematopoietic stem cell transplantation. Jul 2021 [internet publication].Full text

438. European Society for Blood and Marrow Transplantation. COVID-19 and BMT. Jan 2022 [internet publication].Full text

439. American Society of Hematology. COVID-19 and multiple myeloma: frequently asked questions. Jan 2021 [internet publication].Full text

440. Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021 Mar;8(3):e185-93.Full text  Abstract

441. Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. Lancet Haematol. 2020 May 22;S2352-3026(20)30176-9.Full text  Abstract

442. Aydillo T, Gonzalez-Reiche AS, Aslam S, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020 Dec 24;383(26):2586-8.Full text  Abstract

443. Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020 Aug;73(2):451-3.Full text  Abstract

444. Barry A, Apisarnthanarax S, O'Kane GM, et al. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):765-75.Full text  Abstract

445. Narang A, Chan G, Aframian A, et al. Thirty-day mortality following surgical management of hip fractures during the COVID-19 pandemic: findings from a prospective multi-centre UK study. Int Orthop. 2020 Aug 29;1-9.Full text  Abstract

446. Chlebeck JD, Birch CE, Blankstein M, et al. Nonoperative geriatric hip fracture treatment is associated with increased mortality: a matched cohort study. J Orthop Trauma. 2019 Jul;33(7):346-50. Abstract

447. Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 Aug;7(8):e554-64.Full text  Abstract

448. Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020 Nov 19;71(16):2276-8.Full text  Abstract

449. Byrd KM, Beckwith CG, Garland JM, et al. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States. J Int AIDS Soc. 2020 Jul 19;23(7):e25573.Full text  Abstract

450. Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2020 Oct 6;173(7):536-41.Full text  Abstract

451. Nomah DK, Reyes-Urueña J, Díaz Y, et al. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021 Nov;8(11):e701-10.Full text  Abstract

452. Spinelli M, Lynch K, Yun C, et al. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 Jun;8(6):e334-41.Full text  Abstract

453. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021 Nov;8(11):e690-700.Full text  Abstract

454. Mirzaei H, McFarland W, Karamouzian M, et al. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2021 Jan;25(1):85-92.Full text  Abstract

455. Tesoriero JM, Swain CE, Pierce J, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open. 2021 Feb 1;4(2):e2037069.Full text  Abstract

456. Boulle A, Davies MA, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. Aug 2020 [internet publication].Full text  Abstract

457. Chanda D, Minchella PA, Kampamba D, et al. COVID-19 severity and COVID-19-associated deaths among hospitalized patients with HIV infection - Zambia, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 4;70(22):807-10.Full text  Abstract

458. US Department of Health and Human Services. Interim guidance for COVID-19 and persons with HIV. Feb 2022 [internet publication].Full text

459. European AIDS Clinical Society (EACS) and British HIV Association (BHIVA). EACS & BHIVA statement on risk of COVID-19 for people living with HIV (PLWH). Apr 2020 [internet publication].Full text

460. Infectious Disease Society of America and HIV Medicine Association. COVID-19: special considerations for people living with HIV. Dec 2020 [internet publication].Full text

461. European AIDS Clinical Society. COVID-19 and HIV. BHIVA, DAIG, EACS, GESIDA & Polish Scientific AIDS Society. Statement on risk of COVID-19 for people living with HIV (PLWH). May 2020 [internet publication].Full text

462. Netto LC, Ibrahim KY, Picone CM, et al. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet HIV. 2022 May;9(5):e323-e331.Full text  Abstract

463. Guidance for the management of patients with lymphoma during the COVID19 health emergency: a statement from a panel of UK lymphoma experts. Mar 2020 [internet publication].Full text

464. American Society of Hematology. COVID-19 and Hodgkin lymphoma: frequently asked questions. Apr 2022 [internet publication].Full text

465. National Institute for Health and Care Excellence. COVID-19 rapid guideline: interstitial lung disease. May 2020 [internet publication].Full text

466. Canadian Thoracic Society. Optimizing care for patients with interstitial lung disease during the COVID-19 pandemic. Aug 2020 [internet publication].Full text

467. American Society for Hematology. COVID-19 and ITP: frequently asked questions. Apr 2021 [internet publication].Full text

468. Stowe J, Tessier, E, Zhao H, et al. Interactions between SARS-CoV-2 and influenza and the impact of coinfection on disease severity: a test negative design. Int J Epidemiol. 2021;50(4):1124-33.Full text

469. Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. Apr 16;399(10334):1463-4.Full text  Abstract

470. Gleason J, Ross W, Alexander Fossi A, et al. The devastating impact of Covid-19 on individuals with intellectual disabilities in the United States. NEJM Catalyst. Mar 2021 [internet publication].Full text

471. Williamson E, McDonald HI, Bhaskaran K, et al. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021 Jul 14;374:n1592.Full text  Abstract

472. Alexander R, Ravi A, Barclay H, et al. Guidance for the treatment and management of COVID-19 among people with intellectual disabilities. J Policy Pract Intellect Disabil. 2020 Jun 10 [Epub ahead of print].Full text  Abstract

473. Sultan S, Altayar O, Siddique SM, et al. AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020 Jul;159(1):320-34.e27.Full text  Abstract

474. European Academy of Neurology. Headache in COVID-19 pandemic. Apr 2020 [internet publication].Full text

475. Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021 Mar 6;20(3):1-8.Full text  Abstract

476. John TM, Jacob CN, Kontoyiannis DP, et al. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021 Apr 15;7(4):298.Full text  Abstract

477. Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis. 2021 Sep 29;28(1).Full text  Abstract

478. Mejía-Santos H, Montoya S, Chacón-Fuentes R, et al. Notes from the field: mucormycosis cases during the COVID-19 pandemic - Honduras, May-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-9.Full text  Abstract

479. Dulski TM, DeLong M, Garner K, et al. Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1750-1.Full text  Abstract

480. Muthu V, Agarwal R, Patel A, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect Dis. 4 Apr 2022 [Epub ahead of print].Full text  Abstract

481. Department of Health Research Ministry of Health and Family Welfare Government of India. Evidence based advisory in the time of Covid-19. Screening, diagnosis & management of mucormycosis. 2021 [internet publication].Full text

482. Terpos E, Engelhardt M, Cook G, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 2020 Aug;34(8):2000-11.Full text  Abstract

483. British Society for Haematology. UK Myeloma Forum guidance to support medical decision-making in the management of myeloma patients during the COVID-19 (Coronavirus) outbreak. Mar 2020 [internet publication].Full text

484. Medicines and Healthcare products Regulatory Agency guidance. Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19). May 2020 [internet publication].Full text

485. Terpos E, Trougakos IP, Gavriatopoulou M, et al. Low neutralizing antibody responses against SARS-CoV-2 in elderly myeloma patients after the first BNT162b2 vaccine dose. Blood. 2021 Jul 1;137(26):3674-6.Full text  Abstract

486. Ludwig H, Sonneveld P, Facon T, et al. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Haematol. 2021 Dec;8(12):e934-46.Full text  Abstract

487. Association of British Neurologists. ABN guidance on the use of disease-modifying therapies in multiple sclerosis in response to the COVID-19 pandemic. Nov 2020 [internet publication].Full text

488. National Multiple Sclerosis Society. MS treatment guidelines during coronavirus. 2020 [internet publication].Full text

489. Louapre C, Collongues N, Stankoff B, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020 Jun 26;77(9):1-10.Full text  Abstract

490. Salter A, Fox RJ, Newsome SD, et al. Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis. JAMA Neurol. 2021 Jun 1;78(6):699-708.Full text  Abstract

491. MS Society Medical Advisers consensus statement on MS treatments and COVID-19 vaccines. Jan 2022 [Internet publication].Full text

492. Achiron A, Mandel M, Dreyer-Alster S, et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835.Full text  Abstract

493. Disanto G, Sacco R, Bernasconi E, et al. Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis. JAMA Neurol. 2021 Dec 1;78(12):1529-31.Full text  Abstract

494. Brill L, Rechtman A, Zveik O, et al. Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2021 Dec 1;78(12):1510-4.Full text  Abstract

495. König M, Torgauten HM, Tran TT, et al. Immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis and weak immune response after COVID-19 vaccination. JAMA Neurol. 2022 Mar 1;79(3):307-9.Full text  Abstract

496. Madelon N, Heikkilä N, Sabater Royo I, et al. Omicron-specific cytotoxic T-cell responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2022 Apr 1;79(4):399-404.Full text  Abstract

497. American Society for Hematology. COVID-19 and aggressive lymphoma: frequently asked questions. Apr 2022 [internet publication].Full text

498. Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021 Aug 14;398(10300):599-607.Full text  Abstract

499. Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020 May 14;41(19):1839-51.Full text  Abstract

500. Rashid M, Timmis 3A, Kinnaird T, et al. Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021 May;107(9):734-40.Full text  Abstract

501. Public Health England. Excess weight and COVID-19: insights from new evidence. Jul 2020 [internet publication].Full text

502. Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and ,ortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry. Circulation. 2021 Jan 12;143(2):135-44.Full text  Abstract

503. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov;21(11):e13128.Full text  Abstract

504. Kompaniyets L, Goodman A, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-61.Full text  Abstract

505. Arulanandam B, Beladi H, Chakrabarti A. COVID-19 mortality and the overweight: cross-country evidence. Public Health Pract (Oxf). 2021 Nov;2:100179.Full text  Abstract

506. Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-9.Full text  Abstract

507. Holt H, Talaei M, Greenig M, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 30 Nov 2021 [Epub ahead of print].Full text  Abstract

508. Aminian A, Bena J, Pantalone KM, et al. Association of obesity with post-acute sequelae of COVID-19 (PASC). Diabetes Obes Metab. 2021 Sep;23(9):2183-8.Full text  Abstract

509. Lange SJ, Kompaniyets L, Freedman DS, et al. Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2-19 years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1278-83.Full text  Abstract

510. Wanga V, Gerdes M, Shi D, et al. Characteristics and clinical outcomes of children and adolescents aged <18 years hospitalized with COVID-19 - six hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1766-72.Full text  Abstract

511. Maas MB, Kim M, Malkani RG, et al. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath. 2020 Sep 29:1-3 [internet publication].Full text  Abstract

512. Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 Aug;63(8):1500-15.Full text  Abstract

513. Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev. 2020 Sep 8;55:101382 [internet publication].Full text  Abstract

514. European Rhinologic Society. Information for rhinologists on COVID-19. Apr 2020 [internet publication].Full text

515. Royal College of Ophthalmologists. Glaucoma service management plans during COVID-19. Mar 2020 [internet publication].Full text

516. Gittoes NJ, Criseno S, Appelman-Dijkstra NM, et al. Endocrinology in the time of COVID-19: management of calcium disorders and osteoporosis. Eur J Endocrinol. 2020 Aug;183(2):G57-65.Full text  Abstract

517. Yu EW, Tsourdi E, Clarke BL, et al. Osteoporosis management in the era of COVID-19. J Bone Miner Res. 2020 Jun;35(6):1009-13.Full text  Abstract

518. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 3. 2021 Feb;73(2):e1-12.Full text  Abstract

519. Center to Advance Palliative Care. COVID-19 response training. Apr 2020 [internet publication].Full text

520. Jones CM, Radhakrishna G, Aitken K, et al. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. Br J Cancer. 2020 Sep;123(5):709-13.Full text  Abstract

521. Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for deep brain stimulation device management during a pandemic. J Parkinsons Dis. 2020 Jul 28;10(3):903-10.Full text  Abstract

522. Wahezi DM, Lo MS, Rubinstein TB, et al. American College of Rheumatology guidance for the management of pediatric rheumatic disease during the COVID-19 pandemic: version 2. Arthritis Rheumatol. 2021 Aug;73(8):e46-59.Full text  Abstract

523. Zaorsky NG, Yu JB, McBride SM, et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020 Apr 1;5(4):659-65.Full text  Abstract

524. American Society for Hematology. COVID-19 and VTE-anticoagulation: frequently asked questions. Feb 2022 [internet publication].Full text

525. National Institute for Health and Care Excellence. COVID-19 rapid guideline: renal transplantation. Aug 2020 [internet publication].Full text

526. British Transplantation Society and Renal Association. Guidance on management of transplant recipients diagnosed with or suspected of having COVID-19. Jul 2020 [internet publication].Full text

527. The Transplantation Society. Guidance on coronavirus for transplant clinicians. Jun 2020 [internet publication].Full text

528. Kidney Advisory Group, NHS Blood and Transplant. Guidance for re-opening and expansion of kidney transplant programs and COVID-19. Jun 2020 [internet publication].Full text

529. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021 Jun 1;325(21):2204-6.Full text  Abstract

530. Marion O, Del Bello A, Abravanel F, et al. Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants. Ann Intern Med. 2021 Sep;174(9):1336-8.Full text  Abstract

531. Kumar D, Ferreira VH, Hall VG, et al. Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine : secondary analysis of a randomized trial. Ann Intern Med. 2022 Feb;175(2):226-33.Full text  Abstract

532. Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, et al. Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial. JAMA Intern Med. 2022 Feb 1;182(2):165-71.Full text  Abstract

533. Lee AR, Wong SY, Chai LY, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022 Mar 2;376:e068632.Full text  Abstract

534. Zahradka I, Petr V, Modos I, et al. Association between SARS-CoV-2 Messenger RNA Vaccines and lower infection rates in kidney transplant recipients : a registry-based report. Ann Intern Med. 3 May 2022 [Epub ahead of print].Full text  Abstract

535. D'Silva KM, Jorge A, Cohen A, et al. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol. 2021 Jun;73(6):914-20.Full text  Abstract

536. England BR, Roul P, Yang Y, et al. Risk of COVID-19 in rheumatoid arthritis: a national Veterans Affairs matched cohort study in at-risk individuals. Arthritis Rheumatol. 2021 Dec;73(12):2179-88.Full text  Abstract

537. Panamerican League of Associations for Rheumatology. Recommendations for patients on coronavirus. Apr 2020 [internet publication].Full text

538. British Society for Rheumatology. COVID-19: guidance. Mar 2022 [internet publication].Full text

539. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders. Mar 2021 [internet publication].Full text

540. British Society for Rheumatology. Corticosteroid guidance. Nov 2020 [internet publication].Full text

541. Medicines and Healthcare Products Regulatory Agency. Central Alerting System. Ibuprofen and coronavirus (COVID-19). Apr 2020 [internet publication].Full text

542. National Institute for Health and Care Excellence. COVID-19 rapid evidence summary: long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. May 2020 [internet publication].Full text

543. US Food and Drug Administration. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. Mar 2020 [internet publication].Full text

544. European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. Mar 2020 [internet publication].Full text

545. Haberman RH, Castillo R, Chan A, et al. COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes. Arthritis Rheumatol. 2020 Dec;72(12):1981-9.Full text  Abstract

546. European League Against Rheumatism. EULAR guidance for patients COVID-19 outbreak. Apr 2020 [internet publication].Full text

547. Gianfrancesco MA, Leykina LA, Izadi Z, et al. Association of race and ethnicity with COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 Mar;73(3):374-80.Full text  Abstract

548. Arthritis and Musculoskeletal alliance. Principles for COVID-19 vaccination in musculoskeletal and rheumatology for clinicians. Apr 2022 [internet publication].Full text

549. Sweiss NJ, Korsten P, Syed HJ, et al. When the game changes: guidance to adjust sarcoidosis management during the coronavirus disease 2019 pandemic. Chest. 2020 Sep;158(3):892-95.Full text  Abstract

550. Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct;26(10):2473-6.Full text  Abstract

551. Clift AK, Saatci D, Coupland CAC, et al. Sickle cell disorders and severe COVID-19 outcomes: a cohort study. Ann Intern Med. 2021 Oct;174(10):1483-7.Full text  Abstract

552. Sickle Cell Disease Association of America. Sickle cell disease and COVID-19: provider advisory. May 2020 [internet publication].Full text

553. World Health Organization. Smoking and COVID-19: scientific brief. Jun 2020 [internet publication].Full text

554. Hopkinson NS, Rossi N, El-Sayed Moustafa J, et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. 2021 Jul;76(7):714-22. Abstract

555. Clift AC, von Ende A, Tan P, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax. 2022 Jan;77(1):65-73.Full text  Abstract

556. Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021 Nov 16;326(19):1940-52.Full text  Abstract

557. AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020 Jun;51(6):1910-12.Full text  Abstract

558. Stauffer WM, Alpern JD, Walker PF. COVID-19 and dexamethasone: a potential strategy to avoid steroid-related strongyloides hyperinfection. JAMA. 2020 Jul 30;324(7):623-4.Full text

559. Wainwright JJ, Mikre M, Whitley P, et al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA. 2020 Sep 18;324(16):1674-7.Full text  Abstract

560. Ochalek TA, Cumpston KL, Wills BK, et al. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA. 2020 Sep 18;324(16):1673-74.Full text  Abstract

561. Mason M, Arukumar P, Feinglass J, et al. The pandemic stay-at-home order and opioid-involved overdose fatalities. JAMA. 2021 Jun 22;325(24):2495-6.Full text  Abstract

562. Friedman J, Beletsky L, Schriger DL. Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 epidemic. JAMA Psychiatry. 2021 May 1;78(5):562-4.Full text  Abstract

563. Centers for Disease Control and Prevention. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Dec 2020 [internet publication].Full text

564. Pollard MS, Tucker JS, Green HD. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942.Full text  Abstract

565. White AM, Castle IJ, Powell PA, et al. Alcohol-related deaths during the COVID-19 pandemic. JAMA. 2022 May 3;327(17):1704-6.Full text  Abstract

566. U.S. Food and Drug Administration. Possible false RPR reactivity with BioPlex 2200 Syphilis Total & RPR test kit following a COVID-19 vaccine - letter to clinical laboratory staff and health care providers. Dec 2021 [internet publication].Full text

567. Fernandez-Ruiz R, Masson M, Kim MY, et al. Leveraging the United States epicenter to provide insights on COVID-19 in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2020 Dec;72(12):1971-80.Full text  Abstract

568. Rutherford MA, Scott J, Karabayas M, et al. Risk factors for severe outcomes in patients with systemic vasculitis and COVID-19: a binational, registry-Based cohort study. Arthritis Rheumatol. 2021 Sep;73(9):1713-9.Full text  Abstract

569. American Society for Haematology. COVID-19 and thalassemia: frequently asked questions. Jan 2022 [internet publication].Full text

570. Farmakis D, Giakoumis A, Cannon L, et al. COVID-19 and thalassaemia: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020 Oct;105(4):378-86.Full text  Abstract

571. American Society for Hematology. COVID-19 and thrombotic thrombocytopenic purpura: frequently asked questions. Apr 2022 [internet publication].Full text

572. Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Mar 2022 [internet publication].Full text

573. NHS England. COVID-19: provision of tuberculosis services update. Feb 2021 [internet publication].Full text

574. World Health Organization. Tuberculosis and COVID-19. 2020 [Internet publication].Full text

575. World Health Organization. COVID-19 highlights urgent need to reboot global effort to end tuberculosis. Mar 2021 [internet publication].Full text

576. Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 23 Mar 2022 [Epub ahead of print].Full text  Abstract

577. Sebastian S, Walker GJ, Kennedy NA, et al. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-81.Full text  Abstract

578. International Uveitis Study Group. Evolving consensus experience of the IUSG-IOIS-FOIS with uveitis in the time of COVID-19 infection. Apr 2020 [internet publication].Full text

579. Hung JCH, Li KKW. Implications of COVID-19 for uveitis patients: perspectives from Hong Kong. Eye (Lond). 2020 Jul;34(7):1163-64.Full text  Abstract

580. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-78.Full text  Abstract

581. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020 May;115(5):766-73.Full text  Abstract

582. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.Full text  Abstract

583. Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 Apr 21;369:m1443.Full text  Abstract

584. British Society for Haematology. BSH advice on vitamin B12 replacement during the COVID-19 pandemic. May 2020 [internet publication].Full text

585. Hurst EA, Mellanby RJ, Handel I, et al. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study. BMJ Open. 2021 Oct 22;11(10):e055435.Full text  Abstract

586. Dror AA, Morozov N, Daoud A, et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS One. 2022 Feb 3;17(2):e0263069.Full text  Abstract

587. National Institute for Health and Care Excellence. COVID-19 rapid guideline: vitamin D. Dec 2020 [internet publication].Full text

Use of this content is subject to our disclaimer